Filip Krag Knop

Filip Krag Knop

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

    Hansen, K. B., Rosenkilde, Mette, Knop, Filip Krag, Wellner, N., Diep, T. A., Rehfeld, Jens Frederik, Andersen, U. B., Holst, Jens Juul & Hansen, Harald S., 2011, In: Journal of Clinical Endocrinology and Metabolism. 96, 9, p. E1409-17

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552-2554

    Knop, Filip Krag, 1 Apr 2011, In: Diabetes Care. 34, 4, p. e44

    Research output: Contribution to journalLetterResearchpeer-review

  3. Published

    Emerging GLP-1 receptor agonists

    Lund, A., Knop, Filip Krag & Vilsbøll, Tina, 2011, In: Expert Opinion on Emerging Drugs. 16, 4, p. 607-18 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    First case associating chronic pancreatitis and Ehlers-Danlos syndrome

    Hansen, K. B. & Knop, Filip Krag, 2011, In: Pancreas. 40, 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?

    Faurschou, A., Zachariae, Claus, Skov, Lone, Vilsbøll, Tina & Knop, Filip Krag, 1 Oct 2011, In: Medical Hypotheses. 77, 6, p. 1098-1101

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding

    Usinger, Lotte, Hansen, K. B., Kristiansen, V. B., Larsen, S., Holst, Jens Juul & Knop, Filip Krag, 2011, In: Obesity Surgery. 21, 5, p. 625-32 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glucagon antagonism as a potential therapeutic target in type 2 diabetes

    Bagger, J. I., Knop, Filip Krag, Holst, Jens Juul & Vilsbøll, Tina, Nov 2011, In: Diabetes, Obesity and Metabolism. 13, 11, p. 965-971 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

    Christensen, M., Vedtofte, L., Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2011, In: Diabetes. 60, 12, p. 3103-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Impaired regulation of the incretin effect in patients with type 2 diabetes

    Bagger, J. I., Knop, Filip Krag, Lund, Asger Bach, drb459, drb459, Holst, Jens Juul & Vilsbøll, Tina, 2011, In: Journal of Clinical Endocrinology and Metabolism. 96, 3, p. 737-45 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide

    Faurschou, A., Knop, Filip Krag, Thyssen, Jacob Pontoppidan, Zachariae, C., Skov, Lone & Vilsbøll, Tina, 2011, In: Acta Diabetologica.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 40100368